Trial Details
COMPLETEDBasic Information
| Clinical ID | c1895 |
|---|---|
| Identifier | NCT03408470 |
| Trial Title | TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Intestinal Disorders; Bowel Diseases, Inflammatory |
| Interventions | DRUG: TD-1473 oral capsule; DRUG: [14C]-TD-1473 IV bolus; DRUG: [14C]-TD-1473 Oral Capsule |
Participant Information
| Sponsor | Theravance Biopharma |
|---|---|
| City | Lincoln |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | MALE |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-01-31 |
|---|---|
| Primary Completion Date | 2018-02-21 |
| Completion Date | 2018-02-21 |